SMS Pharmaceuticals Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹210.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.19 per cent from ₹242.43 crore. This corresponds to a year-on-year *(YoY) growth of 21.40 per cent.
Operating Profit
Operating Profit stands at ₹43.65 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.76 per cent from ₹48.37 crore. This corresponds to a year-on-year *(YoY) growth of 31.44 per cent.
PBDT
PBDT stands at ₹41.46 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.28 per cent from ₹44.24 crore. This corresponds to a year-on-year *(YoY) growth of 28.36 per cent.
Profit Before Tax
Profit Before Tax stands at ₹31.44 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.12 per cent from ₹34.22 crore. This corresponds to a year-on-year *(YoY) growth of 33.22 per cent.
Net Profit
Net Profit stands at ₹23.47 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 7.27 per cent from ₹25.31 crore. This represents a 28.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
SMS Pharmaceuticals Ltd News
SMS Pharmaceuticals Ltd Earnings
- YOY
- QOQ
SMS Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
SMS Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
SMS Pharmaceuticals Ltd Financial Reports
SMS Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| SMS Pharma. | -0.64% | -0.86% | -4.59% | 11.09% | 40.51% | 49.13% |
| Advanced Enzyme | -0.55% | -2.11% | 21.05% | 18.81% | 10.33% | 23.15% |
| Guj. Themis Bio. | -5.80% | -3.35% | 4.74% | 6.94% | -19.92% | 4.81% |
| RPG LifeScience. | -0.22% | -1.04% | 13.64% | 19.17% | 1.56% | 6.11% |
| Orchid Pharma | -0.26% | 0.59% | 30.02% | 6.43% | -16.22% | -6.22% |
| Aarti Drugs | -0.91% | -2.23% | -0.18% | -1.71% | -19.34% | -24.29% |
| IOL Chemicals | 2.19% | 2.39% | 23.43% | 45.37% | 17.13% | 33.02% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : P Ramesh Babu
Independent Non Exe. Director : Sarvepalli Srinivas
Independent Non Exe. Director : Shravan Kudaravalli
Independent Non Exe. Director : G Suresh Kumar
Independent Non Exe. Director : Shanti Sree Bolleni
Non-Exec & Non-Independent Dir : Trilok Potluri
Non-Exec & Non-Independent Dir : Sunkara Venkata Satya Shiva Prasad
Executive Director : Vamsi Krishna potluri
Company Sec. & Compli. Officer : Thirumalesh Tumma